500660:BOM
GlaxoSmithKline Pharmaceuticals Ltd
₹ २,५६७.२५
arrow_upward
+१.७५%(+४४.२५) 1D
अक्टोबर १६, १५:३०:०० GMT+५:३० · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 500660...
Open
₹ २,५२७.२५
High
₹ २,५७२.४०
Low
₹ २,५२७.२५
Mkt. cap
४.३५ खरब
Avg. vol.
५.०३ हजार
Volume
२.३७ हजार
Dividend
२.२२%
Quarterly dividend
₹ १४.२५
Ex-dividend date
२०२६ मे २९
P/E ratio
४०.७२
52-wk high
₹ ३,१२१.१०
52-wk low
₹ २,०८८.००
EPS
₹ ६३.०५
Shares outstanding
१६.९४ करोड
No. of employees
३ हजार
Open
₹ २,५२७.२५
High
₹ २,५७२.४०
Low
₹ २,५२७.२५
Mkt. cap
४.३५ खरब
Avg. vol.
५.०३ हजार
Volume
२.३७ हजार
Dividend
२.२२%
Quarterly dividend
₹ १४.२५
Ex-dividend date
२०२६ मे २९
P/E ratio
४०.७२
52-wk high
₹ ३,१२१.१०
52-wk low
₹ २,०८८.००
EPS
₹ ६३.०५
Shares outstanding
१६.९४ करोड
No. of employees
३ हजार
News stories
From web sources and news partners
Yahoo! Finance Canada
·
८ मिनेट पहिले
TRIN,FFIN,VIRC,GRNT,GAIA,AFCG,NRGV,AUBN,BETR,NTHI,HERZ,EFOR,SRAD,AVBC,NXRT,GO,CULP,BLCO,VSNT,BLIN,SSP,RVSB,AWRE,APCX,KLTR | Stock Prices | Quote Comparison
FOREX.com
·
२८ मिनेट पहिले
S&P 500, Nasdaq, Dow and Russell 2000 For the Week Ahead
tech-insider.org
·
२ घण्टा पहिले
Trump Calls AI Warnings ‘HOAX’, Nasdaq Drops 0.9% [2026]
MarketWatch
·
१ दिन पहिले
Don’t buy this dip: Several signs suggest there’s more pain ahead for tech stocks
Profile
GlaxoSmithKline Pharmaceuticals Ltd is an Indian research-based pharmaceutical and healthcare company, and a subsidiary of GSK. The company's product portfolio includes prescription medicines and vaccines. Its prescription medicines range across therapeutic areas such as anti-infectives, dermatology, gynaecology, diabetes, oncology, cardiovascular disease, and respiratory diseases. It also offers a range of vaccines, for the prevention of hepatitis A, hepatitis B, invasive disease caused by H, influenzae, chickenpox, diphtheria, pertussis, tetanus, rotavirus, cervical cancer, and others. Wikipedia
About GlaxoSmithKline Pharmaceuticals Ltd